CHANGES IN SYSTEMIC LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER INTRAVITREAL INJECTION OF AFLIBERCEPT OR BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

To analyze and compare the effects of intravitreal brolucizumab versus aflibercept on systemic vascular endothelial growth factor (VEGF)-A levels in patients with neovascular age-related macular degeneration. METHODS: In this prospective interventional case series study, brolucizumab (6.0 mg/50 µL)...

Descripción completa

Detalles Bibliográficos
Autores principales: Angermann, Reinhard, Huber, Anna Lena, Nowosielski, Yvonne, Salcher, Stefan, Gasser, Thomas, Seifarth, Christof, Kralinger, Martina T., Zehetner, Claus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Retina 2022
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852685/
https://www.ncbi.nlm.nih.gov/pubmed/34731094
http://dx.doi.org/10.1097/IAE.0000000000003344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852685/
https://www.ncbi.nlm.nih.gov/pubmed/34731094
http://dx.doi.org/10.1097/IAE.0000000000003344

Ejemplares similares